News: Press Release

1 August 2022

Dexa Award Science Scholarship 2022 Stimulates Innovation to Build Health Independence

The Indonesian government continues to encourage the resilience and independence of the healthcare industry, as imports dominate 90% of its domestic pharmaceutical raw materials and health spending. In addition, 88% of medical device transactions through electronic catalogs (e-catalogs) are imported products. Meanwhile, research and development funds are only about 0.2%…
18 March 2022

Dexa Group Attends the Inauguration of the 'Pengabdian Dokter Indonesia' Monument in Memory of Indonesian Doctors Who Served During the Pandemic

The Indonesian Doctors Association inaugurated the erection of a monument named "Pengabdian Dokter Indonesia" to remember the services of doctors who died to preserve the lives of Indonesians while dealing with COVID-19. Dexa Group took part in the establishment and inauguration of the monument, which took place on Thursday, March…
25 February 2022

Journey with Pinisi, OMAI Expedition Donates Medicines for Public Health in South Sulawesi

To improve public health and handle stunting issues in South Sulawesi, Dexa Group donated Indonesian Indigenous Modern Medicines (OMAI). The OMAI donation was symbolically handed over during the OMAI Expedition at the Bangga Buatan Indonesia & Bangga Wisata Indonesia Sulawesi Selatan 2022 South Sulawesi 2022 event at Losari Beach Pavilion,…
11 February 2022

Recent Study Reveals Vitamin D Lowers the Severity of COVID-19 Symptoms

COVID-19 confirmed cases in Indonesia have consistently increased, as of today, there are more than 230,000 active cases. The government has guaranteed the availability of antiviral medicines following the third wave of COVID-19 strikes across the country due to the Omicron variant. Then how is the availability of vitamins in…
1 September 2021

Dexa Group Ramps Up Business in SE Asia by Launching Glorious Dexa Singapore Pte. Ltd.

Dexa Group, the leading pharmaceutical company from Indonesia, is ramping up its business in Southeast Asia with the launch of Glorious Dexa Singapore, Pte. Ltd. (GDS) based in Singapore. Dexa Group has exported medicines to various countries starting with Myanmar since 1993 and began exporting international standard medicines to Singapore…
2 August 2021

Regdanvimab Reduced The Risk of COVID-19-related Hospitalization or Death for Patients with Comorbidities

Regdanvimab (RegkironaTM) is recommended to treat confirmed COVID-19 in adult patients who do not require supplemental oxygen therapy and are at high risk of progressing to severe COVID-19. The recommended dosage of Regdanvimab is a single intravenous infusion of 40 mg/kg. Treatment should be initiated as soon as possible after…
30 April 2021

ASIMOR Supports the Success of Exclusive Breastfeeding

Entering the month of Ramadan, breastfeeding mothers or mothers are often hit by concerns regarding the adequacy of milk production needed by the baby. Even though this can be overcome by making a number of preparations so that even though they are fasting, the quality and quantity of breast milk…
7 April 2021

Indonesian National Police and Health Workers Get Vaccines and Maintain Body Immune

Police officers and health workers as the front line in the implementation of the Covid-19 vaccine need to get maximum protection. In addition to using personal protective equipment (PPE) and implementing health protocols, maximum protection for the body's immune system also needs to be sought. Commercial Director of PT Dexa…
26 March 2021

Deputy Minister of Health: OMAI Must Be in the JKN E-Catalog Listing

The support for Indonesia Indigenous Modern Medicine (OMAI) to be included in the National Health Insurance (JKN) program continues to be supported. This support surfaced in the 2nd Webinar Series held by the University of Indonesia Board of Trustees (MWA UI) with the theme "Indonesian Health Resilience and Independence" on…
26 March 2021

Dexa Award Science Scholarship 2021: Indonesia Needs More Health Scientist

Indonesia needs more scientist in the health sector to address various health problems, especially related to the Covid-19 pandemic. For information, the total number of researchers in Indonesia is still minimal. According to the 2017-2045 National Research Master Plan, currently, there are only 80 researchers per 1 million population, while…